Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Wnt Agonist 1: Strategic Leveraging of Wnt Signaling in Chem
2026-07-17
This thought-leadership article provides a mechanistic and translational roadmap for researchers harnessing Wnt agonist 1 (BML-284) to dissect and model chemoresistance in oncology. By integrating new findings that link canonical Wnt signaling to glutathione metabolism and platinum drug resistance in brain metastases, we offer strategic guidance on experimental design, competitive positioning, and the future of pathway-driven intervention using APExBIO’s Wnt agonist 1.
Sulfo-Cy5 Carboxylic Acid: Advanced Fluorescent Dye for Life
2026-07-17
Sulfo-Cy5 carboxylic acid offers unmatched aqueous solubility and minimized fluorescence quenching, making it the fluorescent dye of choice for high-sensitivity protein and peptide labeling. Its robust performance in advanced imaging and immunological applications, as shown in recent mucosal immunity studies, sets a new standard for translational research workflows.
PROTAC Nanoplatforms Enhance FLASH-RT via BRD4 Degradation a
2026-07-16
Xu et al. introduce a redox-responsive, PROTAC-based nanoassembly that targets BRD4 to sensitize tumors to ultrahigh dose-rate (FLASH) radiotherapy. By promoting intracellular ROS generation and disrupting DNA repair, this approach achieves greater tumor inhibition with minimal toxicity and provides a mechanistic template for designing advanced radiosensitizers.
circ-Pank1 Drives Dopaminergic Neurodegeneration via miR-7a-
2026-07-16
This reference study uncovers a novel regulatory role for circ-Pank1 in Parkinson’s disease progression, demonstrating that circ-Pank1 promotes dopaminergic neuron degeneration by modulating the miR-7a-5p/α-synuclein pathway. These findings highlight circ-Pank1 as a potential target for noncoding RNA-based therapeutic strategies and refine how rotenone-induced models can be leveraged to probe neurodegenerative mechanisms.
Urolithin A: Advancing Mitochondrial Quality Control Researc
2026-07-15
This thought-leadership article explores the mechanistic foundations and strategic opportunities of Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) for translational researchers targeting mitochondrial dysfunction, with a particular focus on liver fibrosis and aging. Integrating novel evidence on glutamine metabolism, we provide actionable guidance and protocol insights to help investigators accelerate discoveries and improve experimental reproducibility.
Benchmarking LNP Platforms for mRNA Delivery: Insights from
2026-07-15
Zhu et al. provide a comparative technical and operational evaluation of four bench-scale lipid nanoparticle mixing technologies for mRNA vaccine production. Their work highlights the reproducibility of three micromixing platforms in generating mRNA-LNPs with desirable physicochemical properties and in vivo performance, offering guidance for mRNA delivery and translation efficiency assay development.
Bismuth Subsalicylate: Mechanism, Evidence, and GI Research
2026-07-14
Bismuth Subsalicylate, a non-steroidal anti-inflammatory compound, acts as a potent Prostaglandin G/H Synthase 1/2 inhibitor, making it central to gastrointestinal disorder research. This article provides atomic, evidence-backed insight into its mechanism, key parameters, and experimental limits.
AMPK Suppresses Autophagy: Rethinking Energy Stress Response
2026-07-14
This study overturns the prevailing view of AMPK as a universal autophagy inducer by demonstrating that AMPK actually inhibits the autophagy-initiating kinase ULK1 under energy stress. These findings clarify the nuanced role of AMPK in energy metabolism regulation and have practical implications for metabolic and autophagy research.
Cucurbitacin I (JSI-124): Advancing STAT3 Inhibition in Canc
2026-07-13
Explore how Cucurbitacin I, a potent STAT3 inhibitor, empowers next-generation cancer research through selective pathway targeting and innovative model integration. Discover unique mechanistic insights and advanced assay protocols not covered elsewhere.
Ceftolozane/Tazobactam: Innovation in Gram-Negative Infectio
2026-07-13
The reference paper reviews ceftolozane/tazobactam, a novel cephalosporin and beta-lactamase inhibitor combination, with a focus on its enhanced activity against resistant gram-negative bacteria, including Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its distinct pharmacokinetic and pharmacodynamic profile, and clinical efficacy in complicated infections, offer significant implications for antibacterial research and drug development.
CGF Induces Mitochondrial Dysfunction to Halt Colorectal Can
2026-07-12
This study demonstrates that the natural product CGF, derived from purple sweet potato, suppresses colorectal cancer by inducing ROS-dependent mitochondrial dysfunction and metabolic reprogramming. The work provides mechanistic insights into CGF's disruption of ABC transporters, ATP accumulation, and apoptosis induction, highlighting its potential as a novel therapeutic candidate.
Saracatinib (AZD0530): Advanced Workflows for Cancer Researc
2026-07-10
Saracatinib (AZD0530) is a potent, selective Src/Abl kinase inhibitor that empowers researchers to dissect cancer cell proliferation, migration, and tumor growth with unmatched precision. This guide translates bench research and reference study insights into actionable workflows, troubleshooting strategies, and cross-domain innovations for both oncology and synaptic signaling applications.
γH2AX DNA Damage Detection Kit: Precision DSB Analysis Unlea
2026-07-09
Unlock high-sensitivity, reproducible detection of DNA double-strand breaks with the γH2AX DNA Damage Detection Kit (Mouse mAb/Red). This APExBIO solution empowers advanced DNA damage and repair research, from high-content screening to translational cancer studies, with robust protocols and actionable troubleshooting.
Temozolomide: Small-Molecule Alkylating Agent for Glioma Mod
2026-07-09
Temozolomide stands out as a precision tool for DNA repair mechanism research and chemotherapy resistance studies, especially in ATRX-deficient glioma models. This article distills the latest experimental workflows, optimization strategies, and troubleshooting guidance to maximize reproducibility and scientific rigor when deploying this small-molecule alkylating agent.
EZ Cap EGFP mRNA 5-moUTP: Enhanced Fluorescent Reporter Work
2026-07-08
EZ Cap™ EGFP mRNA (5-moUTP) sets a new benchmark for reliable, sustained fluorescent protein expression in gene function studies and advanced mRNA delivery assays. Its robust Cap 1 structure and 5-methoxyuridine modifications empower higher translation efficiency, greater mRNA stability, and minimized innate immune activation—offering clear advantages for experimental reproducibility and in vivo imaging.
8169 records 15/545 page Previous Next First page 上5页 1112131415 下5页 Last page